Henry Schein, Inc. (HSIC)
NASDAQ: HSIC · Real-Time Price · USD
68.29
-0.33 (-0.48%)
Mar 31, 2025, 1:09 PM EDT - Market open
Henry Schein Revenue
In the year 2024, Henry Schein had annual revenue of $12.67B with 2.71% growth. Henry Schein had revenue of $3.19B in the quarter ending December 28, 2024, with 5.77% growth.
Revenue (ttm)
$12.67B
Revenue Growth
+2.71%
P/S Ratio
0.69
Revenue / Employee
$506,920
Employees
25,000
Market Cap
8.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2024 | 12.67B | 334.00M | 2.71% |
| Dec 30, 2023 | 12.34B | -308.00M | -2.44% |
| Dec 31, 2022 | 12.65B | 246.00M | 1.98% |
| Dec 25, 2021 | 12.40B | 2.28B | 22.55% |
| Dec 26, 2020 | 10.12B | 133.20M | 1.33% |
| Dec 28, 2019 | Pro | Pro | Pro |
| Dec 29, 2018 | Pro | Pro | Pro |
| Dec 30, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 26, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
HSIC News
- 6 days ago - Henry Schein Will Showcase a Selection of the Company's Comprehensive Solutions for Oral Health Professionals at the 2025 International Dental Show - Business Wire
- 20 days ago - Ethisphere Names Henry Schein as One of the 2025 World's Most Ethical Companies® for 14th Consecutive Year - Business Wire
- 20 days ago - Henry Schein Looks Bullish (Technical Analysis) - Seeking Alpha
- 26 days ago - Henry Schein: An Industry Leader That Offers Some Upside From Here - Seeking Alpha
- 4 weeks ago - Henry Schein to Participate in Upcoming Investor Conference in March - Business Wire
- 4 weeks ago - Nominations Now Open for Henry Schein Medical's Athletics and Schools 2025 Rising Star Award - Business Wire
- 4 weeks ago - Henry Schein, Inc. (HSIC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Henry Schein Q4 Earnings And Outlook Miss Expectations, Restructures For Growth - Benzinga